| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5130237b112bdc95435e51dacb2ff35b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21a02c29a61bbe4f96a1caca2e287008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16f738f22180aca3437ed65d556f1bc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4c003f04fd1f6a77e4ebf4db330ab87 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2839 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2019-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f00f0931a0b14440ca0b2484b6bbead2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21a2220ee727bac033610c4874cacbd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cae9078331d5ea608ff879d5f2cb7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a58eb43b442cbc0a638f7e158a48586 |
| publicationDate |
2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019169317-A1 |
| titleOfInvention |
Methods and compositions for treating natalizumab-associated progressive multifocal encephalopathy |
| abstract |
Described herein are methods and compositions useful in natalizumab-associated progressive multifocal encephalopathy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022229302-A1 |
| priorityDate |
2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |